Key result
Multidisciplinary cardio-oncology care optimizes management of cancer therapy-related heart failure, arrhythmias, and ischemia.
Optimal management of cardiovascular disease and treatment-related cardiotoxicity in cancer patients requires personalized, multidisciplinary collaboration across all cardiology subspecialties and oncology.
Answers are grounded in this paper and cite their sources.
May support multidisciplinary cardio-oncology models; extends strain imaging data while leaving outcome trials open.
Cardio-Oncology is the care of cancer patients with cardiovascular disease, overt or occult, already established or acquired during treatment. Cancer patients can present with a variety of cardiovascular problems not all of which are directly related to cancer therapy (medications or radiotherapy). The cardiovascular problems of oncology patients can range from ischaemia to arrhythmias and can also include valve problems and heart failure. As such, within cardiology, teamwork is required with members of different cardiology subspecialties. The way forward will be to adopt a multidisciplinary approach to produce optimal individual care. Close collaboration between cardiology and oncology specialists in a Cardio-Oncology setting can make this happen.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2017) conducted a review in Cardiovascular disease in cancer patients (Cardio-Oncology). Multidisciplinary Cardio-Oncology care was evaluated. Cardio-Oncology care requires a multidisciplinary approach across cardiology subspecialties and oncology to manage therapy-related cardiotoxicities including heart failure, arrhythmias, and ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: